Tirzepatide 30mg
Tirzepatide is a 39-amino-acid dual GIP and GLP-1 receptor agonist studied for glycaemic control and body-weight endpoints. This research vial contains 30mg of lyophilized powder, ≥99% HPLC purity.
Volume pricing — buy more, pay less per vial
Select a tier to set the quantity. Discount is applied automatically at checkout.
COA with every batch
Independent EU lab, ≥99% HPLC
Secure encrypted checkout
Card payments over TLS
Discreet packaging
Plain outer box, no branding
EU dispatch in 24–48h
Tracked delivery
Cold-chain handling
Temperature-controlled transit
About this compound
What Is Tirzepatide?
Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual agonist of the GIP and GLP-1 receptors. It is built on a GIP backbone modified with a C20 fatty diacid moiety, which drives albumin binding and extends the plasma half-life to roughly five days — supporting once-weekly dosing schedules in clinical research protocols.
Key Mechanisms
- GLP-1 receptor agonism — glucose-dependent insulin secretion, suppressed glucagon release, delayed gastric emptying and reduced central appetite drive
- GIP receptor agonism — amplifies insulin response and appears to improve adipose tissue insulin sensitivity and lipid handling
- Dual-incretin synergy — the combined receptor profile produces larger effects on weight and HbA1c than GLP-1 mono-agonism in comparative trials
- Albumin-mediated half-life extension — the C20 diacid chain slows renal clearance
Research Applications
- Type 2 diabetes and glycaemic-control models
- Obesity and body-composition research
- Insulin sensitivity and beta-cell function studies
- Comparative incretin pharmacology vs. GLP-1 mono-agonists
Handling
Supplied lyophilized. Reconstitute with bacteriostatic water. Store the sealed vial at 2–8 °C; once reconstituted, keep at 2–8 °C and use within 28 days. Avoid repeated freeze-thaw cycles and vigorous shaking.
Supplied strictly for laboratory and in-vitro research use only. Not for human or veterinary use, not for consumption.
Specifications
- Sequence
- GIP/GLP-1 dual receptor agonist
- Molecular Weight
- 4813.5 Da
- Amino Acids
- 39
- Half-Life
- ~5 days
- CAS Number
- 2023788-19-2
- Vial Size
- 30mg
- Purity
- ≥99% (HPLC)
- Form
- Lyophilized powder
- Reconstitution
- Bacteriostatic water (0.9% benzyl alcohol)
- Storage
- Sealed: 2–8 °C · Reconstituted: 2–8 °C, use within 28 days
Research library
Full mechanism breakdowns and peer-reviewed references for this compound.
Frequently asked questions
Related research compounds
For laboratory and in-vitro research use only. Not for human or veterinary use, not for consumption. By purchasing, you confirm you are a qualified researcher and accept full responsibility for compliant handling and disposal. Read the full disclaimers.